Inventor · disambiguated record
David Rabuka
Also filed as: RABUKA DAVID
41 granted patents·17 pending applications·154 citations·filing 2003–2025
97Inventor score
Files withSCHERER TECHNOLOGIES LLC R P26REDWOOD BIOSCIENCE INC21ACRIGEN BIOSCIENCES3MERCK SHARP & DOHME3ACRIGEN BIOSCIENCES INC1
Top patents by PatentIndex Score
58 records- 0195US9833515B2Hydrazinyl-indole compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2016·Granted Dec 5, 2017·11 cites·12 claims
- 0295US9310374B2Hydrazinyl-indole compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2013·Granted Apr 12, 2016·16 cites·13 claims
- 0393US10604483B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2019·Granted Mar 31, 2020·5 cites·16 claims
- 0492US10888623B2Hydrazinyl-indole compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2019·Granted Jan 12, 2021·3 cites·15 claims
- 0592US10464894B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2016·Granted Nov 5, 2019·5 cites·14 claims
- 0692US9493413B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2014·Granted Nov 15, 2016·8 cites·17 claims
- 0791US9181343B2Antibody specific for CD22 and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2013·Granted Nov 10, 2015·13 cites·30 claims
- 0890US10314919B2Hydrazinyl-indole compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2017·Granted Jun 11, 2019·3 cites·17 claims
- 0990US10183998B2Aldehyde-tagged immunoglobulin polypeptides and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2016·Granted Jan 22, 2019·5 cites·20 claims
- 1090US9879249B2Aldehyde-tagged protein-based drug carriers and methods of useREDWOOD BIOSCIENCE INC·Filed 2015·Granted Jan 30, 2018·6 cites·26 claims
- 1189US11180451B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2019·Granted Nov 23, 2021·2 cites·20 claims
- 1289US7601695B2Antibacterial agentsOPTIMER PHARMACEUTICALS INC·Filed 2004·Granted Oct 13, 2009·34 cites·30 claims
- 1388US11097013B2Anti-HER2 antibody-maytansine conjugates and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2018·Granted Aug 24, 2021·3 cites·29 claims
- 1488US9540438B2Aldehyde-tagged immunoglobulin polypeptides and methods of use thereofBARFIELD ROBYN M·Filed 2012·Granted Jan 10, 2017·16 cites·44 claims
- 1586US10259871B2Antibody specific for CD22 and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2015·Granted Apr 16, 2019·4 cites·30 claims
- 1685US9200026B2Antibacterial agentsMERCK SHARP & DOHME·Filed 2012·Granted Dec 1, 2015·8 cites·20 claims
- 1784US12018308B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2023·Granted Jun 25, 2024·0 cites·20 claims
- 1882US9238878B2Aldehyde-tagged protein-based drug carriers and methods of useRABUKA DAVID·Filed 2010·Granted Jan 19, 2016·9 cites·24 claims
- 1980US11376334B2Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugateSCHERER TECHNOLOGIES LLC R P·Filed 2020·Granted Jul 5, 2022·1 cites·16 claims
- 2080US2023068124A1Hydrazinyl-Indole Compounds and Methods for Producing a ConjugateREDWOOD BIOSCIENCE INC·Filed 2022·Application pending·0 cites
- 2179US2024101975A1Antibody Conjugates and Methods of Making and Using the SameSCHERER TECHNOLOGIES LLC R P·Filed 2023·Application pending·0 cites
- 2277US12296021B2Antibody conjugates and methods of making and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2022·Granted May 13, 2025·0 cites·13 claims
- 2377US12116409B2Antibody specific for CD22 and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2021·Granted Oct 15, 2024·0 cites·35 claims
- 2477US11655492B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2021·Granted May 23, 2023·0 cites·10 claims
- 2575US12215080B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2021·Granted Feb 4, 2025·0 cites·21 claims
- 2675US11788066B2Antibody conjugates and methods of making and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2021·Granted Oct 17, 2023·0 cites·29 claims
- 2774US11426465B2Hydrazinyl-indole compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2020·Granted Aug 30, 2022·0 cites·19 claims
- 2874US9951367B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2015·Granted Apr 24, 2018·1 cites·16 claims
- 2974US2024342303A1Sulfatase-Cleavable Linkers for Antibody-Drug ConjugatesSCHERER TECHNOLOGIES LLC R P·Filed 2024·Application pending·0 cites
- 3073US11053529B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2020·Granted Jul 6, 2021·0 cites·25 claims
- 3172US10683527B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2019·Granted Jun 16, 2020·0 cites·37 claims
- 3272US2025381290A1Antibody Conjugates and Methods of Making and Using the SameSCHERER TECHNOLOGIES LLC R P·Filed 2025·Application pending·0 cites
- 3372US2024360123A1Anti-CD25 Antibody-Maytansine Conjugates and Methods of Use ThereofSCHERER TECHNOLOGIES LLC R P·Filed 2023·Application pending·0 cites
- 3472US2025084182A1Antibody specific for mucin-1 and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2024·Application pending·0 cites
- 3569US12076411B2Anti-HER2 antibody-maytansine conjugates and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2021·Granted Sep 3, 2024·0 cites·27 claims
- 3669US10124070B2Anti-HER2 antibody-maytansine conjugates and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2015·Granted Nov 13, 2018·1 cites·26 claims
- 3767US11980668B2Sulfatase-cleavable linkers for antibody-drug conjugatesSCHERER TECHNOLOGIES LLC R P·Filed 2019·Granted May 14, 2024·0 cites·15 claims
- 3866US11970546B2Antibody specific for Mucin-1 and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2021·Granted Apr 30, 2024·0 cites·23 claims
- 3966US11857637B2Anti-CD25 antibody-maytansine conjugates and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2021·Granted Jan 2, 2024·0 cites·22 claims
- 4066US11466096B2Antibody conjugates and methods of making and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2018·Granted Oct 11, 2022·0 cites·26 claims
- 4165US10344311B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2018·Granted Jul 9, 2019·0 cites·24 claims
- 4262US10758628B2Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugateSCHERER TECHNOLOGIES LLC R P·Filed 2018·Granted Sep 1, 2020·0 cites·15 claims
- 4362US2019352395A1Antibody specific for cd22 and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2019·Application pending·0 cites
- 4461US11208632B2Antibody conjugates and methods of making and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2017·Granted Dec 28, 2021·0 cites·19 claims
- 4561US2019062342A1Novel antibacterial agentsMERCK SHARP & DOHME·Filed 2018·Application pending·0 cites
- 4660US12385025B2Compositions and methods for nucleic acid modificationsACRIGEN BIOSCIENCES·Filed 2025·Granted Aug 12, 2025·0 cites·16 claims
- 4759US2024392272A1Compositions and methods for nucleic acid modificationsACRIGEN BIOSCIENCES·Filed 2022·Application pending·0 cites
- 4859US2025152724A1Antibody conjugates specific for mucin-1 and methods of use thereofSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 4958US2024376509A1Methods of Controlling Cleavage of Formylglycine-Containing PolypeptidesSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 5057US10195283B2Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugateSCHERER TECHNOLOGIES LLC R P·Filed 2017·Granted Feb 5, 2019·0 cites·17 claims
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David Rabuka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →